• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,022.21 -281.42
( -0.36%)
Global Indices
Nasdaq
49,198.35 -53.37
(-0.11%)
Dow Jones
7,195.79 9.71
(0.14%)
Hang Seng
59,839.06 -698.30
(-1.15%)
Nikkei 225
10,331.11 -47.97
(-0.46%)
Forex
USD-INR
93.91 -0.14
(-0.15%)
EUR-INR
110.02 0.03
(0.03%)
GBP-INR
127.00 0.16
(0.13%)
JPY-INR
0.59 0.00
(-0.03%)

EQUITY - MARKET SCREENER

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
578.2640535
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
66.82
171900.2
EPS(TTM)
Face Value()
Div & Yield %
96.91
2
0.46
 

Zensar Technologies consolidated net profit rises 19.39% in the March 2026 quarter
Apr 24,2026
Net profit of Zensar Technologies rose 19.39% to Rs 210.60 crore in the quarter ended March 2026 as against Rs 176.40 crore during the previous quarter ended March 2025. Sales rose 6.73% to Rs 1450.40 crore in the quarter ended March 2026 as against Rs 1358.90 crore during the previous quarter ended March 2025.

For the full year,net profit rose 19.21% to Rs 774.60 crore in the year ended March 2026 as against Rs 649.80 crore during the previous year ended March 2025. Sales rose 7.70% to Rs 5687.40 crore in the year ended March 2026 as against Rs 5280.60 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1450.401358.90 7 5687.405280.60 8
OPM %16.2415.64 -16.1115.47 -
PBDT298.10253.60 18 1137.90959.60 19
PBT275.40229.80 20 1046.60857.70 22
NP210.60176.40 19 774.60649.80 19